Blood matrix effects for male and female Wistar rats, in simultaneous HPLC-UV determination of riparin I and III from Aniba riparia (Nees) Mez. (Lauraceae)  by dos Santos, Sócrates Golzio et al.
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Aniba  riparia  (Nees)  Mez.  (Lauraceae)  is  popularly  known  as  “louro”,  and  is  found  in Amazonia  and  in
the Guianas,  its distribution  extends  to the  Andes.  Alkamide  alkaloids  were  isolated  from  its  green  fruit;
they were  denominated  riparin  I  (methyl  ether  of  N-benzoyl  tyramine),  riparin  II (methyl  ether  of  N-2-
hydroxy-benzoyl  tyramine)  and  riparin  III (methyl  ether  of  N-2,6-dihydroxy-benzoyl  tyramine)  in tribute
to the  plant.  When  administered  orally  and  intraperitoneally  to mice,  riparin  I and  III  are  anxiolytic,  yet
without  any  sedative  or muscle  relaxing  effects.  The  present  study  shows  that  variables  such  as  extraction
solvent,  centrifugation  force,  and  centrifugation  time,  are  important  in  the  simultaneous  liquid–liquid
extraction  of  riparin  I  and  III from  male  and  female  Wistar  rat  blood  in  HPLC-UV  studies.  The study
conﬁrms  matrix  inﬂuence  on  simultaneous  recovery  and  detection  of  riparin  I and  III. The  effect  of  rat
blood matrix  for riparin  I was −13.86%,  while  for  riparin  III it was  −10.94%.  The  recovery  for  riparin  I  was
82.14%,  while  for  riparin  III it was  87.42%.  The  efﬁciency  of the  process  was  73.25%  for  riparin  I and  77.81%
for  riparin  III, demonstrating  an  optimal  method  for simultaneous  recovery  of  riparins  I and  III  from  the
blood of  rats.  The  matrix  effect  for rat  blood  showed  values  of 10.25%  for riparin  I  and  −83.01% for  riparin
III.  Recovery  for  riparin  I was  113.11%,  whereas  for riparin  III it was  13.65%.  The  process  efﬁciency  of  this
method  for  female  rat  blood  was 125.88%  for  riparin  I and  2.58%  for  riparin  III. Simultaneous  recovery
of  riparin  I and III from  the  blood  of male  and  female  rats  using  acetonitrile  as  the precipitating  solvent,
while  centrifuged  at 10,000  ×  g for 10 min  demonstrated  the  importance  of the  parameters  chosen  for
rocesthe  extraction/recovery  p
. Introduction
The family Lauraceae encompasses 52 genera and 3,000 species
ispersed around the world. They are predominantly found in
ropical and subtropical regions, especially in Central and South
merican forests, and usually in temperate zones as well [1].  In
razil, we ﬁnd the family represented by 22 genera which are gen-
rally arboreal [2].
Brazilian Neotropical Lauraceae are economically, and ecolog-
cally important [3],  as many of species of the family are used in
opular medicine for cutaneous lesions, gastric disturbances [4,5],
s an anti-inﬂammatory, and for circulatory problems in both west-
rn and eastern cultures [4],  they also have hypoglycemic [5] and
nxiolytic properties [6].
Aniba riparia (Nees) Mez. (Lauraceae) is popularly known as
louro” and is found in Amazonia and the Guianas, and as far
∗ Corresponding author. Tel.: +55 83 3216.7427.
E-mail address: marcelosobral@ltf.ufpb.br (M.S. da Silva).
039-9140 © 2011 Elsevier B.V. 
oi:10.1016/j.talanta.2011.09.008
Open access under the Elsevier OA license.s  of different  analytes.
© 2011 Elsevier B.V. 
west as the Andes. Alkamide alkaloids were isolated from the
green fruit of this plant, and were called riparin I (methyl ether
of N-benzoyl tyramine) (Fig. 1A) and riparin III (methyl ether of
N-2,6-dihydroxy-benzoyl tyramine) (Fig. 1B) [7].  Riparins I and III,
when administered orally or intraperitoneally in mice showed anx-
iolytic effects, yet without any sedative or muscle relaxing effects,
thus eliminating the common side effects associated with classic
benzodiazepines [8,9].
Biological matrix effects are undesireable for analyte studies
and can result in either suppression or increases in ionic sig-
nal, sensitivity variance over time in analyte detections, baseline
increases, data imprecision, retention time alterations, peak shape
distortions and/or chromatographic tails [10–12].  Signal diminu-
ition in the matrix recovery is one of the effects of endogenous
compound binding, and analyte metabolism in biological ﬂuids
[13,14].
Open access under the Elsevier OA license.Clean-up procedures for biological ﬂuids, such as plasma, are
used to separate endogenous material from the analyte. The sen-
sitivity and selectivity of an assay are affected by the efﬁciency of
the clean-up procedures [15–17].
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Fig. 1. (A) Structure of riparin I and (B) structure of riparin III.
No bioanalytical methods for riparin I and III determinations
ave been previously reported in the literature, and there are no
ublished pharmacokinetic studies for these substances since these
ypes of studies require delineation of blood matrix effects [18].
The present study demonstrates that centrifugation force
nd time, and the extraction solvent used for simultaneous
iquid–liquid extraction of riparin I and III from male and female
istar rat blood are important variables in determinating the
xtent of matrix effect when using high-performance liquid chro-
atography with UV detection (HPLC-UV).
. Experimental
.1. Chemical products, reagents and animais
Riparin I and III were obtained by organic synthesis and donated
y PhD Stanley Juan Chavez Gutierrez, and PhD José Maria Barbosa
ilho of the Paraiban Federal University of Brazil, in accordance with
he methodology described in the literature [19].
For all experiments, ultra-pure water (type I) from an Option-Q
urelab labwater-system (Elga, São Paulo, Brazil), both HPLC-grade
cetonitrile (MeCN) and HPLC-grade metanhol (MeOH) from TEDIA
São Paulo, Brazil), and EDTA supplied by HEMSTAB Laboratory (São
aulo, Brazil) were used.
The blood used was collected from male and female Wistar rats
8–10 weeks, weighing 250–300 g), in tubes with EDTA. The ani-
als were from the Prof. Dr. Thomas George Animal House and
ept under standard laboratory conditions: controlled temperature
21 ± 1 ◦C), light/dark cycle (12 h), with pelleted feed and water
d libitum. The whole study was approved by the Committee on
thics in Research Animals (CEPA) under protocol No. 0107/08, of
he Laboratório de Tecnologia Farmacêutica, Universidade Federal
a Paraíba, João Pessoa/Paraíba, Brazil. The protocols conformed to
he guidelines of the National Institute of Health (NIH Publication,
ealth Research Extension Act of 1985, Public Law 99-158, Novem-
er 20, 1985 “Animals in Research”) for the care and utilization of
aboratory animals.
.2. Instrumentation and chromatographic conditionsChromatography was performed utilizing the HPLC-UV Shi-
adzu Serie 10A vp system, consisting of a Shimadzu LC-10 AD
p pump with FCV-10AL vp solenoid valve, SIL-10AD vp auto-
njector, Shimadzu CTO-10AS vp oven, DGU-14h degasser, and aa 86 (2011) 233– 240
SPD-10AV vp detector. The separation was  carried out with an ACE
C18 (250 mm × 4.6 mm,  5 m)  column equipped with an ACE C18
(4.6 mm)  guard column. The mobile phase used was (20:80, v/v,
H2O:MeCN), at a ﬂow rate of 1 mL  min−1. The wavelength of the UV
detector used for analysis was 225 nm,  column temperature was
controlled at 27 ◦C, and the auto-injector temperature controlled
at 4 ◦C. The sample injection volume was 20 l. Under these con-
ditions, riparin I and riparin III have respective retention times of
7.89 ± 0.2 min  and 10.03 ± 0.2 min.
The samples of rat blood were gently vortexed (AP-56-
TECNAL/PHOENIX) and centrifuged utilizing a Sigma Laborven-
trisugen 2K15 centrifuge.
2.3. Preparation of standard solutions
The stock solutions of riparin I and III were prepared separately
in H2O:MeCN (50:50, v/v,) at a concentraction of 1 mg  mL−1 and
stored at 4 ◦C.
2.4. Preparation of samples in blood, samples in solution and
samples for quality control
Riparin I (1 mg  mL−1) and III (1 mg  mL−1) were added to sam-
ples of male rat blood (300 l) to obtain a ﬁnal concentration of
100 g mL−1, and the samples were then gently vortexed for 30 s.
The blank rat blood samples were gently vortexed for 30 s. These
procedures were repeated for the female rat blood samples.
Samples of a mixture solution of riparin I and III were pre-
pared from stock solutions (1 mg mL−1) in H2O:MeCN (50:50, v/v)
to obtain ﬁnal concentrations of 100 g mL−1 in 300 l of solution,
and were then gently vortexed for 30 s. The same solution sam-
ples of riparin I and III in H2O:MeCN (50:50, v/v) were prepared for
quality control (CQ).
2.5. Preparation of the calibration curve
Samples of riparin I and III in H2O:MeCN (50:50, v/v) were pre-
pared at concentrations of 20, 50, 80, 130 and 160 g mL−1 to
obtain a calibration curve of peak area (y) plotted against theo-
retical concentration in g mL−1 (x) with a correlation coefﬁcient
of >0.99, which served to correlate, by linear regression, the peak
areas obtained for the evaluation method at the concentration of
the test substances.
2.6. Method of evaluation
Male rat blood samples were spiked with riparin I and III, and
were prepared in triplicate. A volume of 600 l of MeOH or MeCN
was added, and the tubes were gently vortexed for 1 min and
centrifuged at 10,000 × g, 12,000 × g and 14,000 × g, where each
centrifugation was  for 10, 15 and 20 min  (Table 1). The same pro-
cedure was  performed for female rat blood spiked with riparin I
and III, and solution samples of riparin I and III (H2O:MeCN, 50:50,
v/v) (Table 1).
After centrifugation of the blood samples and solutions, 600 l
each of supernatant was transferred to another tube and then
vacuum-dried at 40 ◦C. The dried samples were reconstituted with
300 l solvent (50:50, v/v, H2O:MeCN). The solution samples of
riparin I and III, and the quality control (CQ), were not submitted
to the extraction process, these groups were used for statistical
comparison with the extracted solution groups of riparin I and III.
From the samples (blood, solutions of riparin I and III, and
quality controls), a 20 l aliquote was injected in duplicate into a
HPLC-UV system and monitored at 225 nm.  The areas of the peaks
were recorded and replicates used to calculate the mean and stan-
dard deviation. The results were correlated by linear regression
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Table 1
Samples of blood and solutions analyzed, varying the solvent type, centrifugal force and time of centrifugation.
Sample Solvent Centrifugal force ( × g) Centrifugtion time (min)
Blood female rats with riparin I and III MeOH 10,000 10
Blood  female rats with riparin I and III MeOH 10,000 15
Blood  female rats with riparin I and III MeOH 10,000 20
Blood  female rats with riparin I and III MeOH 12,000 10
Blood  female rats with riparin I and III MeOH 12,000 15
Blood  female rats with riparin I and III MeOH 12,000 20
Blood  female rats with riparin I and III MeOH 14,000 10
Blood  female rats with riparin I and III MeOH 14,000 15
Blood female rats with riparin I and III MeOH 14,000 20
Blood  female rats with riparin I and III MeCN 10,000 10
Blood  female rats with riparin I and III MeCN 10,000 15
Blood  female rats with riparin I and III MeCN 10,000 20
Blood  female rats with riparin I and III MeCN 12,000 10
Blood  female rats with riparin I and III MeCN 12,000 15
Blood female rats with riparin I and III MeCN 12,000 20
Blood  female rats with riparin I and III MeCN 14,000 10
Blood  female rats with riparin I and III MeCN 14,000 15
Blood  female rats with riparin I and III MeCN 14,000 20
Blood male rats with riparin I and III MeOH 10,000 10
Blood  male rats with riparin I and III MeOH 10,000 15
Blood  male rats with riparin I and III MeOH 10,000 20
Blood  male rats with riparin I and III MeOH 12,000 10
Blood  male rats with riparin I and III MeOH 12,000 15
Blood  male rats with riparin I and III MeOH 12,000 20
Blood  male rats with riparin I and III MeOH 14,000 10
Blood male rats with riparin I and III MeOH 14,000 15
Blood  male rats with riparin I and III MeOH 14,000 20
Blood  male rats with riparin I and III MeCN 10,000 10
Blood  male rats with riparin I and III MeCN 10,000 15
Blood  male rats with riparin I and III MeCN 10,000 20
Blood male rats with riparin I and III MeCN 12,000 10
Blood  male rats with riparin I and III MeCN 12,000 15
Blood  male rats with riparin I and III MeCN 12,000 20
Blood  male rats with riparin I and III MeCN 14,000 10
Blood  male rats with riparin I and III MeCN 14,000 15
Blood  male rats with riparin I and III MeCN 14,000 20
Solution  of riparin I and III MeOH 10,000 10
Solution  of riparin I and III MeOH 10,000 15
Solution  of riparin I and III MeOH 10,000 20
Solution  of riparin I and III MeOH 12,000 10
Solution  of riparin I and III MeOH 12,000 15
Solution  of riparin I and III MeOH 12,000 20
Solution  of riparin I and III MeOH 14,000 10
Solution  of riparin I and III MeOH 14,000 15
Solution of riparin I and III MeOH 14,000 20
Solution  of riparin I and III MeCN 10,000 10
Solution  of riparin I and III MeCN 10,000 15
Solution  of riparin I and III MeCN 10,000 20
Solution  of riparin I and III MeCN 12,000 10
Solution  of riparin I and III MeCN 12,000 15
Solution  of riparin I and III MeCN 12,000 20
Solution  of riparin I and III MeCN 14,000 10
Solution  of riparin I and III MeCN 14,000 15
u
y
2
s
w
w
i
v
v
MSolution  of riparin I and III MeCN 
sing calibration curves. A typical calibration curve was  as follows:
 = 104579x − 127081 (r2 = 0.9972).
.6.1. Evaluation of the matrix effect (ME%)
To evaluate the matrix effect (ME%), the peak areas for the blood
amples containing the standards that underwent extraction (B)
ere compared with the areas of solution samples that also under-
ent extraction (A). Positive values (ME% > 0) demonstrate matrix
nterference, resulting in detection signal increases, and negative
alues (ME% < 0) result in decreasing detection signal, while a zero
alue (ME% = 0) indicates the absence of matrix effect [20,21]:E% =
((
B
A
)
× 100
)
− 10014,000 20
2.6.2. Recovery in relation to extraction process (RE%)
Recovery in relation to the extraction process in solution (RE%)
can be calculated comparing the peak area of the sample that under-
went extraction (B) to the peak area of the control (C) [20,22]:
RE% =
(
B
C
)
× 100
2.6.3. Efﬁciency of the process (EP)
The evaluation of extraction process efﬁciency was determinedby the adapted equation [20,22]:
EP = ((ME + 100) × RE)
100
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braph 1. Evaluation of riparin I and III recoveries from blood, in relation to sex
n  = 108).
.6.4. Statistical analysis
The results of this study were expressed as the mean ± standard
rror for the mean (SEM) of the percentage of recovery. The differ-
nce between the means were considered signiﬁcant when p < 0.05.
tatistical analyses were performed utilizing ANOVA one-way, with
onferroni’s post-test [23].
. Results and discussion
.1. The matrix effect on recovery
In bioanalyses, the biological components of the sample can
ffect detector/analyte response. These phenomena, generically
alled matrix effects degrade quantiﬁcation, and these effects
hould be considered when developing and validating the bioana-
ytical method [24].
.1.1. Effect of sexual blood type
The recovery percentages of riparin I and III were grouped
ccording to the type of blood utilized (with respect to sex), and the
esults are shown in Graph 1. After statistical analysis, it was  seen
hat the bro-rip1 group (male rat blood spiked with riparin I that
nderwent the extraction process) had a mean recovery of 65.44%,
igniﬁcantly different than group sr-rip1 (riparin I solution that also
nderwent extraction) which had a mean recovery of 93.96%. The
tudy with riparin III in male rat blood showed that the groups
ro-rip3 and sr-rip3 differed signiﬁcantly being 28.50% and 89.25%,
espectively. The bra-rip1 group (female rat blood spiked with
iparin I that underwent extraction) showed a mean recovery of
4.26%, signiﬁcantly less than 93.96% for the sr-rip1 group (riparin
 solution that also underwent extraction). For riparin III, the bra-
ip3 group showed a signiﬁcant difference from solution (sr-rip3),
ith values of 20.88% and 89.25%, respectively. On comparing the
ecovery rates of the solutions that underwent extraction (sr-rip1
nd sr-rip1) in relation to the control group (not extracted), there
as no signiﬁcant difference. The recovery of riparin I from female
at blood (bra-rip1) was 74.26%, signiﬁcantly different from 65.44%
n male rat blood (bro-rip1), and for riparin III there was  no dif-
erence in the recovery between male and female rat blood. These
esults demonstrated recovery differences for riparin I and III with
espect to the sex of the animal. The differences can be explained
y a diversity of interfering substances, and their quantity between
he sexes [25,26]. Fischette et al. [27] also demonstrated that sex
nd hormonal conditions are important variables for experimental
eterminations, and perhaps clinical responses to drugs as well..1.2. Effect of the solvent
The data obtained for recovery percentages of riparin I and III
ere grouped according to the type of solvent used and separated
y animal sex, for type of blood. To precipite the large macro-a 86 (2011) 233– 240
molecules and blood cells we  used (methanol or acetonitrile). The
results are shown in Graph 2 (A, male rats; B, female rats).
The results for male rat blood (Graph 2A); the group boh-r1 had
a mean recovery of 53.89%, which was  markedly different from that
for the group soh-r1 (81.28%). For riparin III, the group boh-r3 had
a mean recovery of 3.78%, which was much lower than that for
soh-r3 (87.32%). For the group bcn-r1, the mean recovery value
was 77.04%, not signiﬁcantly different from the 84.46%, observed
for group scn-r1. Riparin III recovery utilizing acetonitrile (bcn-r3)
was 54.58%, signiﬁcantly different than that of scn-r3 (92.47%).
The groups boh-r1 and bcn-r1 (riparin I) were signiﬁcantly
different than boh-r3 and bcn-r3 (riparin III). Methanol as precip-
itating solvent showed a lower mean recovery when compared
to the use of acetonitrile. The signiﬁcant recovery difference
between riparin I and riparin III in male rat blood using acetoni-
trile was  22.46%. They differ structurally by two hydroxyls in the
N-benzoylamide ring of riparin III (Fig. 1B).
The boh-r1 group had a mean recovery of 51.89% for female rat
blood (Graph 2B), a value signiﬁcantly different from the soh-r1
group which had a value of 92.75%. For the bcn-r1 group, mean
recovery was  of 98.00%, which was not signiﬁcantly different from
that of 94.37% for the scn-r1 group. For riparin III (boh-r3), mean
recovery was 2.10% with the use of methanol, which was signif-
icantly lower than soh-r3 at 79.77%, while the use of acetonitrile
showed a mean recovery of 39.55% for bcn-r3, signiﬁcantly lower
than the solution scn-r3, at 86.10%. Comparing the groups (boh-
r1 and bcn-r1) of female rat blood, they showed a difference which
was similar to that observed between boh-r3 and bcn-r3, with both
being signiﬁcant.
Statistical comparison of solvent effect between the blood of
female rats and male rats showed signiﬁcant differences only when
using acetonitrile. A review of the literature between 1980 and
2010, indicates that for each class of molecule, different types of
organic solvents are utilized for extractions from plasma or blood.
Hoellinger et al. [28] used acetonitrile as the extraction solvent for
alkaloids in blood because of the greater rate of recovery. The same
has been shown for alkamides riparin I and III.
3.1.3. Effect of centrifugation
Published studies have shown that the inﬂuence of endogenous
compounds, and different centrifugal forces make it possible to
obtain a greater precipitation of proteins [29].
The data obtained for the recovery percentages of riparin I and III
were grouped in accordance with centrifugal force, and separated
by sexual blood type. The results are presented in Graph 3 (A, male
rats; B, females rats).
The b10k-r1 (male rat blood) group showed a mean recovery
of 70.99%, which was  not statistically different from the 85.14% of
the s10k-r1 group (Graph 3A). Extracted riparin III with a recov-
ery from blood of 38.72% was  signiﬁcantly lower than that from
solution (84.16%). With centrifugation at 12,000 × g, the b12k-r1
group (riparin I in blood) showed a recovery of 58.93%, which was
not signiﬁcantly different from that of solution s12k-r1 (73.00%).
Extraction of riparin III from blood (b12k-r3) was  29.00%, signiﬁ-
cantly less than that from the solution s12k-r3 (100.50%). For the
highest centrifugation force of 14,000 × g, recovery of riparin I from
the blood (b14k-r1) was 66.39%, signiﬁcantly less than the 92.84%,
obtained from solution (s14k-r1), and for riparin III the correspond-
ing values obtained were 17.76% in the b14k-r3 group and 83.08%
for the s14k-r3 group, markedly different. Graph 3A shows that
there was no signiﬁcant difference in recovery of riparin I from
blood using different centrifugation forces, this was unlike the
recovery of riparin III from blood where there was a decrease of
recovery for an increase in centrifugal force, especially between
10,000 × g and 14,000 × g.
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Graph 2. Evaluation of riparin I and III recoveries from
For the female rat blood study (Graph 3B), the b10k-r1 group
howed a recovery of 80.37%, signiﬁcantly less than that for s10k-
1 at (95.47%), riparin III in the b10k-r3 group had a 27.88% recovery,
hich was signiﬁcantly less than that for group s10k-43 (68.93%).
ith greater centrifugal force (12,000 × g), the b12k-41 group
howed a recovery of 70.67%, which is signiﬁcantly less than that
or s12k-r1 (89.60%). Riparin III showed a 15.24% mean recovery
Graph 3. Evaluation of riparin I and III recoveries from blood, ind, in relation to solvent (n = 52; A, males; B, females).
rate from blood of the b12k-r3 group, which was signiﬁcantly less
than that from the solution (s12k-r3; 89.04%). With the highest
centrifugal force used, i.e., 14,000 × g, riparin I recovery from blood
in the b14k-r1 group was 71.72%, signiﬁcantly less than that from
solution (s14k-r1; 96.82%). Riparin III in group b14k-r3, showed
a 19.50% recovery, which is signiﬁcantly less than that of s14k-r3
(91.48%). There were no signiﬁcant differences between riparin I
 relation to centrifugal force (n = 36; A, males; B, females).
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tGraph 4. Evaluation of riparin I and III recoveries from bloo
roups; b10k-r1, b12k-r1 and b14k-r1, nor between the riparin III
roups; b10k-r3, b12k-r3 and b14k-r3, however, these latter groups
id show lower recovery rates than the riparin I groups.
The statistical analysis focused on the spin/force variable
howed no signiﬁcant difference between the blood of male and
emale rats in the recovery of analytes. For both, the blood of male
nd female rats, a low recovery value of riparin III was  obtained.
entrifugation speed inﬂuences the precipitation of proteins, and
he substituents in riparin III increase the afﬁnity to albumin
ecreasing recovery [30].
.1.4. Effect of the time
In general, centrifugation time does not affect the formation of
icelles, but accelerates the separation of phases, just as in con-
entional separations of a precipitate from its originally aqueous
edium [25].
The data obtained in relation to the mean recovery of riparin I
nd III were grouped according to; time of centrifugation utilized
or precipitation of proteins in the blood, and separation by the type
f blood with regard to sex of the animal. The results are shown in
raph 4 (A, male rats; B, female rats).
In the study using male rat blood (Graph 4A), the b10m-r1 group
blood spiked with riparin I centrifuged for 10 min  and put through
xtraction) had a mean recovery of 65.22%. This was signiﬁcantly
ifferent from the 85.97% of the s10m-r1 group (solution of riparin
 centrifuged for 10 min  and put through extraction). For riparin
II, the b10m-r3 group showed a recovery of 28.79%, which was
igniﬁcantly less than that for the drug solution (s10m-r3 group;
5.93%). With a centrifugation time of 15 min, the b15m-r1 group
ad a recovery of 64.66%, which was not signiﬁcantly different
han s20m-r1. For riparin III in blood (b15m-r3), the mean recov-
ry was 28.53%, signiﬁcantly less than that in solution (s15m-r3;
5.73%). With the longest time of 20 min  the recovery of b20m-
1 was 66.43%, signiﬁcantly less than that for s20m-r1 at (86.65%),
or b20m-r3, the mean recovery was 28.16%, signiﬁcantly less than
hat for s20m-r3 (96.08%). Comparison using ANOVA showed noelation to centrifugation time (n = 36; A, males; B, females).
signiﬁcant difference between different centrifugation times for
recovery of riparin I from blood for (b10m-r1, b15m-r1 and b20m-
r1), and riparin III (b10m-r3, b15m-r3 and b20m-r3). These results
corroborate ﬁndings demonstrating that spontaneous equilibrium
in the precipitation of proteins occurs only after long centrifugation
times [31].
Using female rat blood (Graph 4B), the b10m-r1 group was  found
to have a mean recovery of 77.18%, signiﬁcantly less than that for
the s10m-r1 group (95.42%). The recovery from blood was  also less
than that of solution where riparin III showed a value of 20.54%
for the b10m-r3 group, which is signiﬁcantly less than the 88.31%
found for the s10m-r3 group. For 15 min  of centrifugation, the mean
recovery of riparin I from blood in b15m-r1 was 73.20%, signiﬁ-
cantly less than that in s15m-r1 (97.61%). For riparin III, b15m-r3
showed a recovery rate of 20.38%, signiﬁcantly less than that in
s15m-r3 (94.71%). The recovery values for the longest centrifuga-
tion time of 20 min, were 72.39% for the b20m-r1 group which was
signiﬁcantly less than that for s20m-r1 (88.87%), and 21.70% for the
b20m-r3 group, which was signiﬁcantly less than with s20m-r3.
According to a one-way ANOVA with Bonferroni’s post test, the
group comparisons in relation to centrifugation time, and drug
recovery from male and female rat blood, for riparin I as well as
riparin III, did not show signiﬁcant differences. Also we observed
for the blood of both male and female rats a lower recovery value
for riparin III.
3.1.5. Matrix effect
The exact mechanisms of matrix effects are unknown [26], yet
the reproducibility of assay results in bioanalysis is inﬂuenced by
many components of the biological matrix [24]. It was  observed
in the preceding experiments that the recovery of riparin III, lim-
ited the study, of the simultaneous recovery of the two analytes.
Matrix effect can be seen as an undesireable effect of a biological
medium. Graph 5 demonstrates the measurement of this effect in
blood using acetonitrile, and centrifugation at 10,000 × g for 10 min.
The matrix effect (ME%) in male rat blood (Graph 5A) for riparin I
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ME-r 1-m: pe rcent  of  matrix eff ect
in the extraction  of  ripa rin I from
blood  male rats
ME-r 3-m: pe rcent  of  matrix eff ect
in the extraction  of  ripa rin II I from
blood  male rats
ME-r 1-f: pe rcent  of  matrix eff ect  in
the  extraction  of  ripa rin I from
blood f emale rats
ME-r 3-f: pe rcent  of  matrix eff ect  in
the  extraction  of  ripa rin II I from
blood f emale rats
RE-r 1-m: pe rcen tage  of  recovery
in the extraction  of  ripa rin I from
blood  male rats
RE-r 3-m: pe rcen tage  of  recovery
in the extraction  of  ripa rin II I from
blood  male rats
RE-r 1-f: pe rcen tage  of  recovery in
the  extraction  of  ripa rin I from
blood f emale rats
RE-r 3-f: pe rcen tage  of  recovery in
the  extraction  of  ripa rin II I from
blood f emale rats
EP-r1-m: pe rcen tage  of  process
eff iciency  in the extraction  of
ripa rin I from bloo d male rats
EP-r3-m: pe rcen tage  of  process
eff iciency  in the extraction  of
ripa rin II I from bloo d male rats
EP-r1-f: pe rcen tage  of  process
eff iciency  in the extraction  of
ripa rin I from bloo d female rats
EP-r3-f: pe rcen tage  of  process
eff iciency  in the extraction  of
ripa rin II I from bloo d female rats
p < 0,00 1 (**, ## )
p < 0,0001  (*** , ## #)
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Graph 5. Comparative statistical study of riparin I and III reco
as −13.86%, while for riparin III it was −10.94%; there is interfer-
nce by the matrix in the simultaneous recovery of riparin I and III,
iminishing the signal, and as a consequence making the recovery
alues lower. The recovery value (RE%) in Graph 5B for riparin I
as 82.14%, while for riparin III it was 87.42%, where both recover-
es showed values over 80%, and a process efﬁciency (EP%), (Graph
C), of 73.25% for riparin I and 77.81% for riparin III. This demon-
trates a good method for simultaneous recovery of riparins I and
II from male rat blood. The matrix effect (ME%) for female rat blood
Graph 5A) showed values of 10.25% for riparin I and −83.01% for
iparin III; the biological matrix caused an increase in the signal for
iparin I and markedly diminished the signal for riparin III result-
ng in simultaneous recovery disparity. The recovery value (RE%),
raph 5B for riparin I was 113.11%, while for riparin III it was  13.65%.
he process efﬁciency (EP%) for this method in female rat blood
Graph 5C) was 125.88% for riparin I, and (EP%) 2.58% for riparin
II. Components of the blood caused signal suppression for riparin
 and III, yet increased the signal for riparin I in female rat blood.
. Conclusion
In the development of a bioanalytical method, it is important
o remove matrix effects [20]. Process efﬁciency is determined by
he combination of these effects on the recovery and detection of
he extracted analyte. Our studies conﬁrm the critical inﬂuence
f matrix effects on the simultaneous recovery and detection of
iparin I and III. If the interferents in the matrix could be minimized,
he method would provide greater recovery/detection values [32].
hao and Ren [33] demonstated that native BSA contains hydropho-
ic groups in the interior of the tertiary structure, and polar groups in blood, in relation to solvent (n = 52; A, males; B, females).
on the surface which allow binding of ﬂavonoid OH groups to
the polar groups on the surface proteins. They also demonstated
that the binding between ﬂavonoids and albumin is inﬂuenced by
ﬂavonoid hydroxylation. Xiao et al. [34] also studied the inﬂuence
of ﬂavonoid hydroxylation on the interaction with BSA and found
the same result. This would suggest that due to matrix effect, the
recovery of riparin III from rats bloods would be less than that of
riparin I. Our method gave simultaneous recovery of riparin I and
III from blood of male and female rats with the use of acetonitrile
as the precipitating solvent, and centrifugation at 10,000 × g for
10 min.
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